Feasibility study of the BrightBrainer™ integrative cognitive rehabilitation system for elderly with dementia.

Autor: Burdea, Grigore, Polistico, Kevin, Krishnamoorthy, Amalan, House, Gregory, Rethage, Dario, Hundal, Jasdeep, Damiani, Frank, Pollack, Simcha
Předmět:
Zdroj: Disability & Rehabilitation: Assistive Technology; Sep2015, Vol. 10 Issue 5, p421-432, 12p, 3 Color Photographs, 2 Charts, 2 Graphs
Abstrakt: Purpose: To describe the development of BrightBrainer™ integrative cognitive rehabilitation system and determine clinical feasibility with nursing home-bound dementia patients. Method: BrightBrainer cognitive rehabilitation simulations were first played uni-manually, then bimanually. Participants sat in front of a laptop and interacted through a game controller that measured hand movements in 3D, as well as flexion of both index fingers. Interactive serious games were designed to improve basic and complex attention (concentration, short-term memory, dual tasking), memory recall, executive functioning and emotional well-being. Individual simulations adapted automatically to each participant's level of motor functioning. The system underwent feasibility trials spanning 16 sessions over 8 weeks. Participants were evaluated pre- and post-intervention, using standardized neuropsychological measures. Computerized measures of movement repetitions and task performance were stored on a remote server. Results: Group analysis for 10 participants showed statistically significant improvement in decision making ( p < 0.01), with trend improvements in depression ( p < 0.056). Improvements were also seen in processing speed ( p < 0.13) and auditory attention ( p < 0.17); however, these were not statistically significant (partly attributable to the modest sample size). Eight of nine neuropsychological tests showed changes in the improvement direction indicating an effective rehabilitation ( p < 0.01). BrightBrainer technology was well tolerated with mean satisfaction ratings of 4.9/5.0 across participants. Conclusions: Preliminary findings demonstrate utility within an advanced dementia population, suggesting that it will be beneficial to evaluate BrightBrainer through controlled clinical trials and to investigate its application in other clinical populations. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index